Skip to main content
    L

    Longeveron LLC (LGVN)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $2.14
    -0.35 (-14.06%)

    Market Cap: $8.40M

    Last updated: Nov 17, 2026 at 11:03 AM ET

    Longeveron LLC (LGVN) Financials: Revenue, Profit and Cash Flow

    Updated Nov 12, 2026. Financial statements from company filings, amounts in US dollars.

    Longeveron LLC reported revenue of $1.20M for the fiscal year ended Dec 31, 2025, down 49.9% from the year before. That year, net income was -$22.70M with a net margin of -1893.6%, operating cash flow was -$18.64M and free cash flow was -$18.89M. The quarter ended Sep 30, 2026 had revenue of $115.00K and net income of -$6.13M.

    Revenue and Margins

    Over the 7 years to Dec 2025, revenue fell from $2.13M, a compound annual decline of 7.9%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$1.20M-49.9%67.0%-1942.2%-1893.6%
    Dec 2024$2.39M+237.4%78.8%-690.7%-667.8%
    Dec 2023$709.00K-42.0%31.2%-2966.0%-3020.2%
    Dec 2022$1.22M-6.4%40.7%-1476.5%-1541.3%
    Dec 2021$1.31M-76.8%45.2%-1336.6%-1278.1%
    Dec 2020$5.63M0.0%32.4%-67.1%-66.1%
    Dec 2019$5.63M+163.7%32.4%-67.1%-66.1%
    Dec 2018$2.13MN/A31.9%-298.0%-296.8%
    Annual, fiscal years ended Dec 2018 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss widened from the year before. In the quarter ended Sep 2026, the net loss narrowed from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
    Revenue$1.20M$2.39M$709.00K$1.22M$1.31M$5.63M$5.63M$2.13M
    Cost of revenue$396.00K$508.00K$488.00K$725.00K$716.00K$3.80M$3.80M$1.45M
    Gross profit$803.00K$1.88M$221.00K$497.00K$590.00K$1.83M$1.83M$680.65K
    Research and development$12.04M$8.14M$9.07M$9.37M$7.09M$2.67M$2.67M$3.88M
    Operating income-$23.29M-$16.52M-$21.03M-$18.04M-$17.46M-$3.78M-$3.78M-$6.36M
    Net income-$22.70M-$15.97M-$21.41M-$18.84M-$16.69M-$3.72M-$3.72M-$6.34M
    EBITDA-$21.48M-$15.02M-$20.06M-$16.54M-$15.77M-$2.93M-$2.95M-$5.59M
    Fiscal years ended Dec 2018 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$115.00K$287.00K$398.00K$365.00K$137.00K$316.00K$381.00K$603.00K$773.00K$468.00K$548.00K$63.00K
    Gross profit$71.00K$182.00K$264.00K$257.00K$125.00K$146.00K$275.00K$529.00K$682.00K$344.00K$329.00K-$2.00K
    Operating income-$7.20M-$6.17M-$4.78M-$5.40M-$7.31M-$5.40M-$5.18M-$4.28M-$4.65M-$3.50M-$4.09M-$5.44M
    Net income-$6.13M-$6.07M-$4.74M-$5.44M-$7.22M-$5.03M-$5.01M-$4.08M-$4.42M-$3.41M-$4.06M-$6.03M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents exceeded short-term debt of $655.00K by $4.01M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
    Total assets$10.26M$25.56M$12.08M$27.41M$42.77M$9.24M$10.58M$10.52M
    Current assets$5.45M$19.62M$5.85M$20.28M$35.38M$1.85M$2.37M$4.16M
    Cash and equivalents$4.66M$19.23M$4.95M$10.50M$25.66M$816.00K$1.87M$4.03M
    Total liabilities$4.59M$3.67M$5.34M$6.91M$5.31M$7.28M$6.14M$3.71M
    Short-term debt$655.00K$623.00K$593.00K$564.00K$537.00K$177.00K$485.79KN/A
    Long-term debtN/AN/AN/A$2.04M$2.60M$311.00KN/AN/A
    Shareholder equity$5.67M$21.89M$6.74M$20.50M$37.45M$1.96M$4.45M$6.81M
    Fiscal years ended Dec 2018 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$12.02M$15.49M$21.21M$10.26M$15.56M$16.75M$20.85M$25.56M$29.91M$19.39M$9.70M$12.08M
    Total liabilities$7.30M$5.08M$5.18M$4.59M$5.59M$4.09M$3.69M$3.67M$4.28M$4.48M$6.66M$5.34M
    Cash and equivalents$7.25M$10.08M$15.76M$4.66M$9.24M$10.33M$14.33M$19.23M$22.78M$12.38M$1.94M$4.95M
    Shareholder equity$4.71M$10.40M$16.03M$5.67M$9.97M$12.66M$17.16M$21.89M$25.63M$14.91M$3.04M$6.74M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
    Operating cash flow-$18.64M-$13.87M-$19.00M-$13.97M-$9.64M-$2.36M-$2.39M-$5.18M
    Capital expenditures$245.00K$655.00K$301.00K$569.00K$330.00K$131.00K$37.57K$211.68K
    Free cash flow-$18.89M-$14.52M-$19.30M-$14.54M-$9.97M-$2.50M-$2.43M-$5.39M
    Dividends paidN/A$8.65MN/AN/A$451.00KN/AN/AN/A
    Investing cash flow-$595.00K-$640.00K$8.19M-$677.00K-$10.70M-$261.00K-$125.05K-$211.68K
    Financing cash flow$4.67M$28.79M$5.26M-$509.00K$45.17M$1.57M$350.00K$1.35M
    Fiscal years ended Dec 2018 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow-$2.69M-$5.65M-$4.37M-$5.30M-$5.05M-$3.60M-$4.70M-$3.37M-$2.84M-$4.57M-$3.09M-$4.00M
    Capital expenditures$65.00K$103.00K$0$64.00K$57.00K$161.00K$27.00K$13.00K$430.00K$196.00K$16.00K$164.00K
    Free cash flow-$2.75M-$5.76M-$4.37M-$5.36M-$5.11M-$3.76M-$4.72M-$3.39M-$3.27M-$4.76M-$3.10M-$4.16M
    Last 12 quarters

    Frequently Asked Questions About LGVN

    What is Longeveron LLC's annual revenue?

    Longeveron LLC reported revenue of $1.20M for the fiscal year ended Dec 31, 2025.

    How fast is Longeveron LLC's revenue growing?

    Revenue was down 49.9% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -0.6%.

    Is Longeveron LLC profitable?

    No. Longeveron LLC reported net income of -$22.70M for the fiscal year ended Dec 31, 2025, with a net margin of -1893.6%.

    How much free cash flow does LGVN generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of -$18.64M minus capital expenditures of $245.00K produced free cash flow of -$18.89M.

    How much debt does Longeveron LLC have?

    The balance sheet dated Dec 31, 2025 reported short-term debt of $655.00K and cash and equivalents of $4.66M.